Bagnati Pablo M, Londoño Castaño Marisol, Fernández María Laura, Henao Beatriz Mora, Chrem Patricio, Aguillón David, Varela Luz Estela, Barbaran Juan Diego, Leon Yudy, Surace Ezequiel, Madrigal Claudia C, Picasso Juan Pablo, Ramos Claudia P, Fernández Carlos M Restrepo, Vigo Gabriela, Aguilar Laura Ramirez, VargasCuadros Gabriel Alberto, Arcos-Burgos Mauricio, Longoria Erika Mariana, Ziegemeier Ellen, McDade Eric, Bateman Randall J, Allegri Ricardo F, Lopera Francisco, Llibre-Guerra Jorge J
Department of Cognitive Neurology Neuropsychiatry and Neuropsychology Fleni Neurological Research Institute Buenos Aires Argentina.
Grupo de Neurociencias de Antioquia Facultad de Medicina Universidad de Antioquia Medellín Colombia.
Alzheimers Dement (Amst). 2025 Apr 6;17(2):e70102. doi: 10.1002/dad2.70102. eCollection 2025 Apr-Jun.
This study involved evaluating a tailored genetic counseling and testing (GCT) protocol for families at risk of autosomal dominant Alzheimer's disease (ADAD) in Latin America (LatAm), focusing on essential cultural and regional adaptations.
We conducted a non-randomized controlled trial among ADAD families in Colombia and Argentina. Participants were categorized based on their decision to learn their genetic status (GS), with further comparisons between mutation-positive versus mutation-negative participants who learned their status. Psychological impacts were measured using validated scales for anxiety and depression.
Of the 122 eligible participants, 97 completed the GCT protocol, and 87 opted to learn their GS. There were no clinically significant differences in psychological distress between those who learned their status and those who did not, nor between mutation-positive and mutation-negative individuals.
The GCT protocol effectively managed psychological impacts in ADAD families and was positively received, demonstrating the importance of culturally adapted GCT protocols.
We examined the adaptation and efficacy of a GCT protocol in LatAm for families at risk of ADAD.The GCT protocol mitigated psychological distress among at-risk ADAD families.The study confirms the protocol's cultural appropriateness and psychological safety.Future studies should explore the long-term psychological and public health impacts of GCT and use of GCT for treatment options.
本研究旨在评估针对拉丁美洲有常染色体显性阿尔茨海默病(ADAD)风险的家庭量身定制的遗传咨询与检测(GCT)方案,重点关注必要的文化和地区适应性调整。
我们在哥伦比亚和阿根廷的ADAD家庭中进行了一项非随机对照试验。参与者根据其了解自身基因状态(GS)的决定进行分类,并对了解自身状态的突变阳性与突变阴性参与者进行进一步比较。使用经过验证的焦虑和抑郁量表来测量心理影响。
在122名符合条件的参与者中,97人完成了GCT方案,87人选择了解其GS。了解自身状态的参与者与未了解的参与者之间,以及突变阳性和突变阴性个体之间,在心理困扰方面均无临床显著差异。
GCT方案有效管理了ADAD家庭中的心理影响,并获得了积极反馈,证明了文化适应性GCT方案的重要性。
我们研究了拉丁美洲针对有ADAD风险家庭的GCT方案的适应性和有效性。GCT方案减轻了有风险的ADAD家庭的心理困扰。该研究证实了该方案在文化上的适宜性和心理安全性。未来的研究应探讨GCT的长期心理和公共卫生影响,以及将GCT用于治疗选择的情况。